Please provide your email address to receive an email when new articles are posted on . In 2013, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, ...

Dec. 12, 2003 — Editor's Note: On Nov. 14, Eyeonics, Inc., received U.S. Food and Drug Administration (FDA) approval to market the first accommodating intraocular lens (Crystalens) that allows ...

Calgary, Alberta–TheNewswire -November 22, 2024 - Ocumetics Technology Corp. (OTC:CA) (OTCQB:OTCFF) (FRA: 2QBO), a leader inadvanced ophthalmic technology, is pleased to provide an update on internal ...

Please provide your email address to receive an email when new articles are posted on . Ophthalmologists have been searching for effective ways to address presbyopia for many decades, particularly ...

Accommodative IOLs, a new option for lens exchange, are the fastest growing approach to presbyopic IOL use. Although lenses with different mechanisms are in development, the Crystalens IOL (eyeonics, ...

Calgary, Alberta –TheNewswire -June 24, 2025- Ocumetics Technology Corp (OTCFF). (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to confirmthe culmination of nearly two decades of ...

Bausch & Lomb has introduced Crystalens AO, an aberration free accommodating intraocular lens with aspheric optics, according to a Bausch & Lomb news release. The Crystalens AO has prolate aspheric ...

・Ocumetics (TSXV:OTC), an ophthalmic solutions provider, has met its latest milestone with its intraocular lens technology, demonstrating accommodative power using 3D-printed lenses under simulated ...

ReportsnReports.com adds the global intraocular lens (IOL) market is projected to reach USD 4.56 Billion by 2022 from USD 3.50 Billion in 2017, at a CAGR of 5.4%. The growth of this market is majorly ...